|
[1]Schwegler EE, Cazares L, Steel LF, et al.SELDI-TOF MS profi-ling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma[J].Hepatology, 2005, 41∶634-642.
|
|
[1]Schwegler EE, Cazares L, Steel LF, et al.SELDI-TOF MS profi-ling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma[J].Hepatology, 2005, 41∶634-642.
|
|
[2]Paradis V, Degos F, Dargere D, et al.Identification of a newmarker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver disease[J].Hepatology, 2005, 41∶40-47.
|
|
[2]Paradis V, Degos F, Dargere D, et al.Identification of a newmarker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver disease[J].Hepatology, 2005, 41∶40-47.
|
|
[3]Roelofsen H, Balgobind R, Vonk RJ.Proteomic analyzes of copper metabolism in an in vitro model of Wilson disease using surface en-hanced laser desorption/ionization-time of flight-mass spectrome-try[J].J Cell Biochem, 2004, 93∶732-740.
|
|
[3]Roelofsen H, Balgobind R, Vonk RJ.Proteomic analyzes of copper metabolism in an in vitro model of Wilson disease using surface en-hanced laser desorption/ionization-time of flight-mass spectrome-try[J].J Cell Biochem, 2004, 93∶732-740.
|
|
[4]汤钊猷.现代肿瘤学[M].上海:上海医科大学出版社, 1993∶561.
|
|
[4]汤钊猷.现代肿瘤学[M].上海:上海医科大学出版社, 1993∶561.
|
|
[5]Parasole R, Izzo F, Perrone F, et al.Prognostic value of serum bio-logical markers in patients with hepatocellular carcinoma[J].Clin Cancer Res, 2001, 7∶3504-3509.
|
|
[5]Parasole R, Izzo F, Perrone F, et al.Prognostic value of serum bio-logical markers in patients with hepatocellular carcinoma[J].Clin Cancer Res, 2001, 7∶3504-3509.
|
|
[6]李悦国, 张维铭.蛋白质组学在肝癌及其相关疾病研究中的应用[J].中国肿瘤临床, 2005, 32∶957-960.
|
|
[6]李悦国, 张维铭.蛋白质组学在肝癌及其相关疾病研究中的应用[J].中国肿瘤临床, 2005, 32∶957-960.
|
|
[7]Wu W, Hu W, Kavanagh JJ.Proteomics in cancer research[J].Int J Gynecol Cancer, 2002, 12∶409-423.
|
|
[7]Wu W, Hu W, Kavanagh JJ.Proteomics in cancer research[J].Int J Gynecol Cancer, 2002, 12∶409-423.
|
|
[8]Lueking A, Cahill DJ, Mullner S.Protein biochips:A newand ver-satile platform technology for molecular medicine[J].Drug Discov Today, 2005, 10∶789-794.
|
|
[8]Lueking A, Cahill DJ, Mullner S.Protein biochips:A newand ver-satile platform technology for molecular medicine[J].Drug Discov Today, 2005, 10∶789-794.
|
|
[9]Figeys D, Pinto D.Proteomics on a chip:promising developments[J].Electrophoresis, 2001, 22∶208-216.
|
|
[9]Figeys D, Pinto D.Proteomics on a chip:promising developments[J].Electrophoresis, 2001, 22∶208-216.
|
|
[10]Issaq HJ, Veenstra TD, Conrads TP, et al.The SELDI-TOF MS ap-proach to proteomics:protein profiling and biomarker identification[J].Biochem Biophys Res Commun, 2002, 292∶587-592.
|
|
[10]Issaq HJ, Veenstra TD, Conrads TP, et al.The SELDI-TOF MS ap-proach to proteomics:protein profiling and biomarker identification[J].Biochem Biophys Res Commun, 2002, 292∶587-592.
|
|
[11]Petricoin EF, Ardekani AM, Hitt BA, et al.Use of proteomic pat-terns in serum to identify ovarian cancer[J].Lancet, 2002, 359∶572.
|
|
[11]Petricoin EF, Ardekani AM, Hitt BA, et al.Use of proteomic pat-terns in serum to identify ovarian cancer[J].Lancet, 2002, 359∶572.
|
|
[12]Adam BL, Qu Y, Davis JW, et al.Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from algorithm distinguishes prostate cancer from benign pros-tate hyperplasia and healthy men[J].Cancer Res, 2002, 62∶3609.
|
|
[12]Adam BL, Qu Y, Davis JW, et al.Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from algorithm distinguishes prostate cancer from benign pros-tate hyperplasia and healthy men[J].Cancer Res, 2002, 62∶3609.
|
PDF下载 ( 367 KB)
本文二维码
下载:
